메뉴 건너뛰기




Volumn 10, Issue 2, 2008, Pages

Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: A subgroup analysis of the DBCG82 b and c trials

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CA9 PROTEIN, HUMAN; CARBONATE DEHYDRATASE; TUMOR ANTIGEN; TUMOR MARKER;

EID: 48949119479     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1981     Document Type: Article
Times cited : (16)

References (30)
  • 1
    • 0035503362 scopus 로고    scopus 로고
    • Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer
    • Giatromanolaki A, Koukourakis MI, Sivridis E, Pastorek J, Wykoff CC, Gatter KC, Harris AL. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res 2001, 61:7992-7998.
    • (2001) Cancer Res , vol.61 , pp. 7992-7998
    • Giatromanolaki, A.1    Koukourakis, M.I.2    Sivridis, E.3    Pastorek, J.4    Wykoff, C.C.5    Gatter, K.C.6    Harris, A.L.7
  • 2
    • 0028111173 scopus 로고
    • Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment
    • Pastorek J, Pastorekova S, Callebaut I, Mornon JP, Zelnik V, Opavsky R, Zat'ovicová M, Liao S, Portetelle D, Stanbridge EJ, et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 1994, 9:2877-2888.
    • (1994) Oncogene , vol.9 , pp. 2877-2888
    • Pastorek, J.1    Pastorekova, S.2    Callebaut, I.3    Mornon, J.P.4    Zelnik, V.5    Opavsky, R.6    Zat'ovicová, M.7    Liao, S.8    Portetelle, D.9    Stanbridge, E.J.10
  • 4
    • 0035418586 scopus 로고    scopus 로고
    • Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix
    • Loncaster JA, Harris AL, Davidson SE, Logue JP, Hunter RD, Wycoff CC, Pastorek J, Ratcliffe PJ, Stratford IJ, West CM. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 2001, 61:6394-6399.
    • (2001) Cancer Res , vol.61 , pp. 6394-6399
    • Loncaster, J.A.1    Harris, A.L.2    Davidson, S.E.3    Logue, J.P.4    Hunter, R.D.5    Wycoff, C.C.6    Pastorek, J.7    Ratcliffe, P.J.8    Stratford, I.J.9    West, C.M.10
  • 6
    • 84960987950 scopus 로고
    • The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy
    • Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 1953, 26:638-648.
    • (1953) Br J Radiol , vol.26 , pp. 638-648
    • Gray, L.H.1    Conger, A.D.2    Ebert, M.3    Hornsey, S.4    Scott, O.C.5
  • 7
    • 67349283842 scopus 로고    scopus 로고
    • Carbonic anhydrase IX (CA IX) as a predictive marker for benefit from post-mastectomy adjuvant locoregional radiation (RT): Results from the British Columbia (BC) Randomized Radiation Trial
    • Chia S, Ragaz J, Makretsov N, Cheang M, Hayes M, Gilks B, Harris A, Spinelli J, Gelmon K, Olivotto I, Huntsman D. Carbonic anhydrase IX (CA IX) as a predictive marker for benefit from post-mastectomy adjuvant locoregional radiation (RT): Results from the British Columbia (BC) Randomized Radiation Trial. J Clin Oncol 2005, 23:16S.
    • (2005) J Clin Oncol , vol.23
    • Chia, S.1    Ragaz, J.2    Makretsov, N.3    Cheang, M.4    Hayes, M.5    Gilks, B.6    Harris, A.7    Spinelli, J.8    Gelmon, K.9    Olivotto, I.10    Huntsman, D.11
  • 8
    • 33751277287 scopus 로고    scopus 로고
    • CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance
    • 10.1158/1078-0432.CCR-06-0480, 17085655
    • Brennan DJ, Jirstrom K, Kronblad A, Millikan RC, Landberg G, Duffy MJ, Rydén L, Gallagher WM, O'Brien SL. CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance. Clin Cancer Res 2006, 12:6421-6431. 10.1158/1078-0432.CCR-06-0480, 17085655.
    • (2006) Clin Cancer Res , vol.12 , pp. 6421-6431
    • Brennan, D.J.1    Jirstrom, K.2    Kronblad, A.3    Millikan, R.C.4    Landberg, G.5    Duffy, M.J.6    Rydén, L.7    Gallagher, W.M.8    O'Brien, S.L.9
  • 9
    • 34250182435 scopus 로고    scopus 로고
    • Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 study
    • 10.1016/j.radonc.2007.05.009, 17543403
    • Eriksen JG, Overgaard J. Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 study. Radiother Oncol 2007, 83:383-388. 10.1016/j.radonc.2007.05.009, 17543403.
    • (2007) Radiother Oncol , vol.83 , pp. 383-388
    • Eriksen, J.G.1    Overgaard, J.2
  • 10
    • 0036069159 scopus 로고    scopus 로고
    • Expression of carbonic anhydrase IX in breast is associated with malignant tissues and is related to overexpression of c-erbB2
    • 10.1002/path.1120, 12115877
    • Bartosová M, Parkkila S, Pohlodek K, Karttunen TJ, Galbavý S, Mucha V, Harris AL, Pastorek J, Pastoreková S. Expression of carbonic anhydrase IX in breast is associated with malignant tissues and is related to overexpression of c-erbB2. J Pathol 2002, 197:314-321. 10.1002/path.1120, 12115877.
    • (2002) J Pathol , vol.197 , pp. 314-321
    • Bartosová, M.1    Parkkila, S.2    Pohlodek, K.3    Karttunen, T.J.4    Galbavý, S.5    Mucha, V.6    Harris, A.L.7    Pastorek, J.8    Pastoreková, S.9
  • 12
    • 0141751743 scopus 로고    scopus 로고
    • The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis
    • 10.1023/A:1025702330207, 14572156
    • Colpaert CG, Vermeulen PB, Fox SB, Harris AL, Dirix LY, Van Marck EA. The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis. Breast Cancer Res Treat 2003, 81:137-147. 10.1023/A:1025702330207, 14572156.
    • (2003) Breast Cancer Res Treat , vol.81 , pp. 137-147
    • Colpaert, C.G.1    Vermeulen, P.B.2    Fox, S.B.3    Harris, A.L.4    Dirix, L.Y.5    Van Marck, E.A.6
  • 17
    • 0346003770 scopus 로고    scopus 로고
    • Chalkley estimates of angiogenesis in early breast cancer - relevance to prognosis
    • 10.1080/028418602321028337, 14651216
    • Offersen BV, Sorensen FB, Yilmaz M, Knoop A, Overgaard J. Chalkley estimates of angiogenesis in early breast cancer - relevance to prognosis. Acta Oncol 2002, 41:695-703. 10.1080/028418602321028337, 14651216.
    • (2002) Acta Oncol , vol.41 , pp. 695-703
    • Offersen, B.V.1    Sorensen, F.B.2    Yilmaz, M.3    Knoop, A.4    Overgaard, J.5
  • 18
    • 9844227910 scopus 로고    scopus 로고
    • Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial
    • 10.1056/NEJM199710023371401, 9395428
    • Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen MB, Zedeler K. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997, 337:949-955. 10.1056/NEJM199710023371401, 9395428.
    • (1997) N Engl J Med , vol.337 , pp. 949-955
    • Overgaard, M.1    Hansen, P.S.2    Overgaard, J.3    Rose, C.4    Andersson, M.5    Bach, F.6    Kjaer, M.7    Gadeberg, C.C.8    Mouridsen, H.T.9    Jensen, M.B.10    Zedeler, K.11
  • 19
    • 0033562626 scopus 로고    scopus 로고
    • Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial
    • 10.1016/S0140-6736(98)09201-0, 10335782
    • Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, Kamby C, Kjaer M, Gadeberg CC, Rasmussen BB, Blichert-Toft M, Mouridsen HT. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999, 353:1641-1648. 10.1016/S0140-6736(98)09201-0, 10335782.
    • (1999) Lancet , vol.353 , pp. 1641-1648
    • Overgaard, M.1    Jensen, M.B.2    Overgaard, J.3    Hansen, P.S.4    Rose, C.5    Andersson, M.6    Kamby, C.7    Kjaer, M.8    Gadeberg, C.C.9    Rasmussen, B.B.10    Blichert-Toft, M.11    Mouridsen, H.T.12
  • 20
    • 33744804312 scopus 로고    scopus 로고
    • Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies
    • 10.1200/JCO.2005.02.8738, 16618947
    • Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol 2006, 24:2268-2275. 10.1200/JCO.2005.02.8738, 16618947.
    • (2006) J Clin Oncol , vol.24 , pp. 2268-2275
    • Nielsen, H.M.1    Overgaard, M.2    Grau, C.3    Jensen, A.R.4    Overgaard, J.5
  • 23
    • 78650894868 scopus 로고    scopus 로고
    • ER, PgR, HER2 and response to post-mastectomy radiotherapy in high-risk breast cancer. A subgroup analysis of DBCG 82 b&c
    • Kyndi M, Sorensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J. ER, PgR, HER2 and response to post-mastectomy radiotherapy in high-risk breast cancer. A subgroup analysis of DBCG 82 b&c. J Clin Oncol 2008,
    • (2008) J Clin Oncol
    • Kyndi, M.1    Sorensen, F.B.2    Knudsen, H.3    Overgaard, M.4    Nielsen, H.M.5    Overgaard, J.6
  • 26
    • 0036795452 scopus 로고    scopus 로고
    • Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells
    • 10.1210/me.2001-0347, 12351689
    • Stoner M, Saville B, Wormke M, Dean D, Burghardt R, Safe S. Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells. Mol Endocrinol 2002, 16:2231-2242. 10.1210/me.2001-0347, 12351689.
    • (2002) Mol Endocrinol , vol.16 , pp. 2231-2242
    • Stoner, M.1    Saville, B.2    Wormke, M.3    Dean, D.4    Burghardt, R.5    Safe, S.6
  • 27
    • 33646423829 scopus 로고    scopus 로고
    • Hypoxia inducible factor-1alpha is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response
    • 10.1002/ijc.21676, 16381002
    • Kronblad A, Jirstrom K, Ryden L, Nordenskjold B, Landberg G. Hypoxia inducible factor-1alpha is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response. Int J Cancer 2006, 118:2609-2616. 10.1002/ijc.21676, 16381002.
    • (2006) Int J Cancer , vol.118 , pp. 2609-2616
    • Kronblad, A.1    Jirstrom, K.2    Ryden, L.3    Nordenskjold, B.4    Landberg, G.5
  • 28
    • 34250166555 scopus 로고    scopus 로고
    • Differential risk assessments from five hypoxia specific assays: the basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients
    • 10.1016/j.radonc.2007.04.021, 17499868
    • Nordsmark M, Eriksen JG, Gebski V, Alsner J, Horsman MR, Overgaard J. Differential risk assessments from five hypoxia specific assays: the basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients. Radiother Oncol 2007, 83:389-397. 10.1016/j.radonc.2007.04.021, 17499868.
    • (2007) Radiother Oncol , vol.83 , pp. 389-397
    • Nordsmark, M.1    Eriksen, J.G.2    Gebski, V.3    Alsner, J.4    Horsman, M.R.5    Overgaard, J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.